MODIFIED DIRECTLY OBSERVED THERAPY (MDOT) FOR INJECTION DRUG USERS WITH HIV DISEASE
Guardat en:
MCCANCE-KATZ, E., ET AL., MODIFIED DIRECTLY OBSERVED THERAPY (MDOT) FOR INJECTION DRUG USERS WITH HIV DISEASE. AMERICAN JOURNAL ON ADDICTIONS, Vol. 11, no. 4 (2002), p. 271-278.
Ref.
117394
Localització:
SIIS R.1264 Archivo
Palabras clave:
Drogodependencias, Fármacos, Heroína, Metadona, Programas de mantenimiento, Resultados, Sida, Tratamiento, Vía intravenosa, EE.UU.
Drogodependencias, Fármacos, Heroína, Metadona, Programas de mantenimiento, Resultados, Sida, Tratamiento, Vía intravenosa, EE.UU.
Ítems similars: MODIFIED DIRECTLY OBSERVED THERAPY (MDOT) FOR INJECTION DRUG USERS WITH HIV DISEASE
- METHADONE MAINTENANCE TREATMENT AND HIV TYPE 1 SEROCONVERSION AMONG INJECTING DRUG USERS
- TARGETING HIV-RELATED OUTCOMES WITH INTRAVENOUS DRUG USERS MAINTAINED ON METHADONE: A RANDOMIZED CLINICAL TRIAL OF A HARM REDUCTION GROUP THERAPY
- EVALUATION OF BUPRENORPHINE MAINTENANCE TREATMENT IN A FRENCH COHORT OF HIV-INFECTED INJECTING DRUG USERS
- OPTIMAL TARGETING OF HEPATITIS C VIRUS TREATMENT AMONG INJECTING DRUG USERS TO THOSE NOT ENROLLED IN METHADONE MAINTENANCE PROGRAMS
- THE STREET / TREATMENT BARRIER: TREATMENT EXPERIENCES OF PUERTO RICAN INJECTION DRUG USERS
- LONGITUDINAL PREDICTORS OF INJECTION CESSATION AND SUBSEQUENT RELAPSE AMONG A COHORT OF INJECTION DRUG USERS IN BALTIMORE, MD, 1988-2000